John R Koethe Selected Research

Ritonavir (Norvir)

1/2022

Adipokines, Weight Gain and Metabolic and Inflammatory Markers After Antiretroviral Therapy Initiation: AIDS Clinical Trials Group (ACTG) A5260s.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John R Koethe Research Topics

Disease

23	Inflammation (Inflammations) 01/2023 - 04/2011
18	Weight Gain 04/2024 - 04/2010
14	Obesity 01/2024 - 07/2013
14	HIV Infections (HIV Infection) 01/2022 - 09/2009
12	Insulin Resistance 12/2023 - 04/2013
8	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 05/2010
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 04/2013
7	Overweight 01/2023 - 07/2013
7	Hypertension (High Blood Pressure) 09/2022 - 01/2019
7	Malnutrition (Nutritional Deficiencies) 01/2021 - 09/2009
4	Disease Progression 04/2024 - 11/2011
4	Metabolic Diseases (Metabolic Disease) 01/2024 - 05/2016
4	Atherosclerosis 06/2023 - 01/2022
4	Dyslipidemias (Dyslipidemia) 06/2023 - 01/2016
4	Diabetes Mellitus 02/2022 - 05/2016
4	Viremia 01/2022 - 09/2017
3	Type 2 Diabetes Mellitus (MODY) 06/2023 - 01/2023
3	Glucose Intolerance 01/2023 - 01/2018
3	Weight Loss (Weight Reduction) 01/2023 - 01/2023
2	Prediabetic State (Prediabetes) 01/2023 - 01/2023
2	Tuberculosis (Tuberculoses) 01/2023 - 01/2022
2	Non-alcoholic Fatty Liver Disease 01/2023 - 07/2021
2	Schistosomiasis (Bilharziasis) 01/2022 - 01/2020
2	Noncommunicable Diseases 01/2021 - 01/2017
2	Infections 01/2020 - 01/2020
1	Body Weight (Weight, Body) 01/2023
1	Kidney Diseases (Kidney Disease) 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Atrial Fibrillation 02/2022
1	Heart Failure 02/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2022
1	Peripheral Arterial Disease 02/2022
1	Pulmonary Tuberculosis 01/2022

Drug/Important Bio-Agent (IBA)

13	LipidsIBA 12/2023 - 04/2013
9	IntegrasesIBA 04/2024 - 12/2017
8	Biomarkers (Surrogate Marker)IBA 12/2023 - 04/2011
6	C-Reactive ProteinIBA 08/2022 - 06/2012
6	Lipopolysaccharide ReceptorsIBA 01/2022 - 01/2013
5	Tenofovir (Viread)FDA Link 04/2024 - 12/2017
4	tenofovir alafenamideIBA 04/2024 - 01/2020
4	dolutegravirIBA 04/2024 - 12/2017
4	CytokinesIBA 12/2022 - 07/2013
4	Emtricitabine (Emtriva)FDA Link 01/2022 - 12/2017
4	efavirenz (Sustiva)FDA Link 01/2022 - 12/2017
4	Integrase InhibitorsIBA 10/2021 - 01/2020
4	Reverse Transcriptase InhibitorsIBA 12/2020 - 05/2016
4	NucleosidesIBA 12/2020 - 05/2016
4	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2013
3	Triglycerides (Triacylglycerol)IBA 06/2023 - 02/2022
3	HDL CholesterolIBA 06/2023 - 04/2013
3	SaltsIBA 09/2022 - 07/2019
3	LeptinIBA 01/2022 - 06/2012
3	AcidsIBA 01/2022 - 05/2016
3	AdipokinesIBA 01/2022 - 10/2016
3	RNA (Ribonucleic Acid)IBA 12/2020 - 04/2020
3	Protease Inhibitors (Protease Inhibitor)IBA 12/2020 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 01/2016
2	bictegravirIBA 04/2024 - 12/2020
2	2-Aminoadipic Acid (2 Aminoadipic Acid)IBA 06/2023 - 01/2023
2	CalciumIBA 01/2023 - 12/2022
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2023 - 01/2023
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2023 - 01/2023
2	Liraglutide FDA Link 01/2023 - 01/2023
2	CreatinineIBA 01/2023 - 06/2012
2	HDL LipoproteinsIBA 02/2022 - 01/2021
2	AdiponectinIBA 01/2022 - 01/2019
2	Epoxide HydrolasesIBA 01/2022 - 01/2021
2	abacavir (Ziagen)FDA Link 10/2021 - 12/2020
2	Mitochondrial DNA (mtDNA)IBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2017
2	ThymidineIBA 01/2020 - 01/2018
2	Immunologic Factors (Immunomodulators)IBA 01/2020 - 01/2020
2	Human Immunodeficiency Virus ProteinsIBA 01/2020 - 01/2020
2	AntigensIBA 11/2018 - 01/2018
2	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2018 - 05/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 01/2015
2	Viral ProteinsIBA 09/2017 - 10/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 07/2013
2	Phosphates (Orthophosphate)IBA 01/2013 - 05/2010
1	FumaratesIBA 04/2024
1	ChemokinesIBA 01/2023
1	Plasminogen Activator Inhibitor 1IBA 01/2023
1	CarbohydratesIBA 01/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023
1	IncretinsIBA 01/2023
1	Illicit Drugs (Recreational Drugs)IBA 01/2023
1	MicronutrientsIBA 01/2023
1	EpitopesIBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 12/2022
1	Hemoglobins (Hemoglobin)IBA 08/2022
1	Glycoproteins (Glycoprotein)IBA 08/2022
1	Atazanavir Sulfate (Reyataz)FDA Link 01/2022
1	EnzymesIBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	EicosanoidsIBA 01/2022

Therapy/Procedure

37	Art Therapy 04/2024 - 09/2009
29	Therapeutics 01/2024 - 04/2010
4	Highly Active Antiretroviral Therapy (HAART) 10/2021 - 07/2011
2	Caloric Restriction 12/2023 - 01/2023
1	Duration of Therapy 12/2022